According to Mao et al., lncRNA P53RRA could activate the p53 pathway in a dose-dependent manner by interacting with G3BP1 in the cytoplasm, thereby promoting ferroptosis in lung cancer (50). This evidence concerns the gene TP53 and lung carcinoma.